Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by <sup>1</sup>H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution

8 Nov 2011

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis and is highly chemoresistant. Early detection is the only means to impact long-term survival, but screening methods are lacking. Given the complex and heterogeneous nature of pancreatic cancer, unbiased analytical methods such as metabolomics by nuclear magnetic resonance (NMR) spectroscopy show promise to identify disease-specific molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Metabolomics and Mass Spectrometry Studies
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22066465
DOI: 10.1021/pr200960u

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by <sup>1</sup>H Nuclear Magnetic Resonance: Identification, Mapping, and EvolutionPMID 22066465Read ↗

Metabolic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African AncestrySemantic proximity Read ↗

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.Semantic proximity Read ↗

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Functional metabolic phenotyping of human pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Metabolomic profiling of pancreatic adenocarcinoma reveals fundamental clinical featuresSemantic proximity Read ↗

Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry.Semantic proximity Read ↗

NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.Semantic proximity Read ↗

Multi-dimensional metabolomic profiling reveals dysregulated ornithine metabolism hallmarks associated with a severe acute pancreatitis phenotype.Semantic proximity Read ↗

Automated analysis of large-scale NMR data generates metabolomic signatures and links them to candidate metabolitesSemantic proximity Read ↗

Fast targeted multidimensional NMR metabolomics of colorectal cancerSemantic proximity Read ↗

Metabonomic profiling of oesophageal cancerSemantic proximity Read ↗

Phenylketonuria (PKU) Urinary Metabolomic Phenotype Is Defined by Genotype and Metabolite Imbalance: Results in 51 Early Treated Patients Using Ex Vivo 1H-NMR Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.